chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient became dizzy and light headed, passed out into chair (briefly), employee felt tightness in chest, SOB, taken to emergency room at this point, increased heart rate, blood pressure and SOB. Patient given Neb treatment, Solu-Medrol, Toradol (for migraine). Patient discharged from emergency room with improved breathing. Patient reports she is still SOB at times, has muscle aches, fatigue and soreness at injection site.
pt recvd 4th dose of vax & exp peripheral cyanosis on both legs; lips were also blue; h/o cyanotic congenital heart disease & underwent heart surgery w/in days of birth;
The patient was administered a Moderna COVID-19 booster dose that had surpassed the refridgeration experation date by one day. Per our pharmacy, this Moderna COVID-19 vaccine (LOT #045L21A) expired on 4/6/2022 at 15:11. The patient received a booster dose on 4/7/2022 at 8:31 AM. No adverse reactions were documented after the patient was administered this vaccine.
Moderna vaccination inadvertently administered to subject at age 17 yrs 8 mo when its recommended for 18 yrs and older. No adverse reaction has been reported to Public Health by the recipient or either of her parents who also received their vaccinations at the same vaccination clinic.
On 1/20/2006 MMR vaccine dose #1 adminstered  for negative mump titer (0.52). No adverse events occured after vaccination. On 3/7/2006 MMR vaccine dose #2 adminstered. Approx 10 minutes after giving vaccination Patient c/o feeling hot & itchy on the inside. Denies feeling itchy on the outside. Noted redness on the upper chest and palms of hands. Forearms were slightly mottled in appearance and a non-raised area of redness was noted on R hand(approx 5mm). Patient took benadryl 50mg PO approx 20 minutes after the onset of symptoms. VS 128/86, Pulse 72, Resp 20. No respiratory distress, no swelling, no hives, and no skin rashes. Approx 30 minutes after taking Benadryl the symptoms resolved. Patient states she had a rebound of her symptoms later that evening at 8:00pm: c/o redness around the trunk of her body, hands, & neck along with feeling itchy on the inside. Took another 50mg of Benadryl PO and symptoms resolved approx 30minutes after taking.   Today patient reported that she has been experiencing joint discomfort/ aching pain in knees and lower backs since the evening of 3/8/06. Taking OTC Motrin with relief.
Within 3 hours of vaccination developed, fever, chills, apalling headache,total body ache and sore throat.  Lasted for about 3 days, still had sore throat and nasal congestion for about 10 days.
Approximately 24 hours after vaccines pt started with crying and that has lasted for 2 more days. He has also has a temp to 101 degrees F and mild runny nose and mild cough.
30 minutes after receiving vaccine developed shortness of breath, throat tightness, itchy throat/mouth, body spasm and extreme pain to upper and lower extremities, difficulty walking. The next day felt fatigue and hand twitching. Then, developed stutter, difficulty speaking, involuntary head movement and hand jerking, brain fog, headaches, and loss of coordination.
Bruising at injection site, large area of pain/erythema (about 4in x 3in) around injection site.
Face swelling. "Red" super hot cheeks. No fever. Felt fine other than extremely red face and mildly swollen cheekbone area. Overall felt hot across whole body, no fever. Injection site was sore but tolerable.
Vaccine administered 9.20am. Fatigue shortly after vaccine was administered - slept most of afternoon. Injection site pain - feels like been punched in arm. Headache in the evening. Night chills and complained of "tight" (not acute) chest pain... but no breathing problems. Morning fever of 101F. Headache, Dizzy, Fatigue, Muscle Pain (esp in legs, asif he had "run a marathon"). He spent most of the day "resting".  Evening on day two, we noticed a large bump under his vaccinated arm. Radius about 5cm - larger than what I know swollen lymph nodes to look like - almost looks like a bicep between his armpit and nipple. Tender to touch. Morning of day three (48 hours after vaccine) bump under his arm remains and all other symptoms seem milder.
Intense pain in arm, could not move arm, difficulty breathing. Morphine for Pain, Medrol.
Site of injection swollen, warm, reddened, and tender.  Site very itchy, reddness measuring approximately 2 to 3 inches in diameter.  Site improving with application of hydrocortisone creme for inflammation and warm moist compresses.
This case was reported by a other health professional via call center representative and described the occurrence of injection site pain in a patient who received BEXSERO (batch number 154101A, expiry date May 2017). Previously administered products included BEXSERO (1st dose received on an unknown date without experiencing any an adverse event). On 12th September 2016, the patient received the 2nd dose of BEXSERO. In September 2016, less than a week after receiving BEXSERO, the patient experienced injection site pain, low back pain and fever. On an unknown date, the outcome of the injection site pain, low back pain and fever were not recovered/not resolved. It was unknown if the reporter considered the injection site pain, low back pain and fever to be related to BEXSERO. Additional details were provided as follows: Age at vaccination was not reported. the patient's date of birth was reported as 29th June (healthcare professional refused to give year of birth). the patient experienced injection site pain (arm), lower back pain and low grade fever after receiving 2nd dose of BEXSERO.
w/in 1 hr of vax pt went limp turned pale, could not be awakened, got fever of 102 R-remained lethargic-moaning as if body ached for 72hrs; slept continuously ate very little, whimpered weakly;
First night: fever, chills, headache  Second day: fatigue, slight headache, slight fever, nausea  Third day: fatigue, slight nausea, slight fever
Myalgia, injection site reaction Narrative: Employee reports injection site pain/discomfort and swelling, in addition to "slight" body aches. Reports took ibuprofen 200 mg x 2 doses. Reports feeling better day after receiving vaccine and has been able to work with no complaints.
pt recv vax & exp redness, pain, itching, & swelling (grapefruit size) @ the inj site;the events last over 2wk;sx are currently resolved;
It has been 4 weeks now and I have generalized weakness, brain fogginess, fatigue, the upper right side of my body is weak, I have muscle tension in my right arm, right side of the neck and right jaw. Buzzing feelings in right foot and ankle. Seeing black spots on things off an on. Like I am seeing an insect on an object that is not really there.
Woke up next day with chills, muscle aches, fatigue, runny nose. unable to stay warm on a sunny 60 degree day. Low grade fever 99.1F, resting wrist pulse 82, I?m usually around 60.
Expired Pediarix administered; This case was reported by a physician via call center representative and described the occurrence of expired vaccine used in a patient who received DTPa-HBV-IPV (Pediarix) for prophylaxis.   Co-suspect products included dtpa-hbv-ipv vaccine pre-filled syringe device (Pediarix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 6th September 2022, the patient received Pediarix and Pediarix Pre-Filled Syringe Device. On 6th September 2022, unknown after receiving Pediarix and Pediarix Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 06-SEP-2022 Reporter's Comment: The reporter reported that, a patient inadvertently received an expired dose of Pediarix at the time of reporting. The reporter was not asked but no further information was provided regarding patient or product. The reporter consented to follow up. Additional Supportive Information: The reporter reported that, a patient inadvertently received an expired dose of Pediarix at the time of reporting, which led to expired vaccine used.
Patient vaccinated x5 (2/16/21, 3/16/21, 11/22/21, 5/27/22, 11/16/22). Patient tested COVID+ and admitted to hospital on 11/21/22
One day after the first vaccine, my menstral cycle came a 5 days early. I thought it was odd but did not consider it further. 21 days later after my second vaccine, my cycle started two days after the vaccine, which is 8 days too early from the start of my last cycle and 15 days too early from normal.
15 min after getting her vaccine, individual felt lightheaded.  HR:60/min, BP 120/60.  @ 13:05 pt. ate a protein bar (she didn't have breakfast), individual also drink plenty of water.  Pt states she feels better.  1310PM pt called her ride to be picked.  Pt left the facility at 13:30, asymptomatic.
Information has been received from a licensed practical nurse concerning a 25 year old female with allergic reaction to CIPRO, BACTRIM, who on 04-MAY-2010 was vaccinated with the first dose of GARDASIL (0.5ml, IM, lot # 665768/1354Y) in the left arm deltoid. Concomitant therapy included TRINESSA. "within 24 hours of immunization, the patient developed hives on her body. There were no labs or diagnostic tests performed. The patient made a phone call to medical attention. At time of reporting, the patient was recovering. Additional information has been requested.
dizziness (within first 10 minutes), vertigo ,confusion,  migraine, bradycardia (heart rate dropped to 49, 50, 52 then 53), night sweats, swelling throat ( took 3 crushed antihistamines--2 then 2 hours later a 3rd-- and reported this to the ER nurse).  It felt as if someone was sitting on my chest and my head was a hot air balloon. I used breathing techniques learned in previous therapy sessions to control my breathing and take shallow breaths. I moved very little so as to not alter my breathing pattern. Talking and swallowing unusually interrupted my breathing so I limited talking. I spit my saliva in empty water bottles to avoid swallowing.   The dizziness and vertigo was so intense that I laid down the first three days. I only got off of my beanbag to go use the restroom.  I used my fitness Watch to document my heart rate before I was able to get myself to an ER (I am also uninsured since my health insurance expired two months prior and have been waiting for approval.)  By 12/31, I couldn't take it anymore so that was when I took the 2 antihistamines and visited an ER--taking the 3rd one while waiting. I also took 10mg Rizatriptan on this date  for the migraine.  After 1/1 I felt much better and all of the pre existing reactions dissipated. I have an appt with a Neurologist this week 1/6 as well as cardiologist to make sure that this did not further affect me in any way.
My sinus infection is not related to the vaccine. I flew (two legs of a flight each way), attended a wedding and visited family. The morning after my return flight I had a sore throat, nasal congestion. I took Robitusin for 6 days but developed green mucous in my sinuses. I then contacted my NP (6/30) and was prescribed anixucukkub0ckavykabate 875-125 mg per tablet. I took that for 12 days and continued with Robitusin DM as prescribed.
pt had a birthday between dose1 and dose2.  pt got pfizer-ped at 11yo and pfizer-ped after she turned 12.  No adverse events noted by the mother.
01/01/22 presents to ED for "shortness of breath". PMHx of "atrial fibrillation with RVR, chronic diastolic heart failure, type 2 diabetes mellitus, DVT, hyperlipidemia, hypertension, anxiety, restrictive lung disease, pulmonary embolism on L quests, renal mass, liver nodules, liver mass, and superobesity"
Headache; Chills; Fatigue; This is a spontaneous report received from a contactable consumer (patient). Follow-up (25Feb2021) was received from same reporter and processed together with initial information.   A 31-year-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; solution for injection, Lot number: EL3247) via an unspecified route of administration on 16Feb2021 09:15 (at the age of 31-year-old) as 2nd dose, single in left arm for covid-19 immunization. The patient's medical history was not reported and had no known allergies. The patient did not receive any other vaccine within 4 weeks prior to the vaccine. The patient did not take any medications within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient was not pregnant at the time of vaccination. The patient received first dose of BNT162B2 (Lot number: EL3247) via an unspecified route of administration on 26Jan2021 at 14:30 (at the age of 31-year-old) as 1st dose, single in left arm for covid-19 immunization. On 16Feb2021 at 12:30, the patient experienced headache, chills, fatigue. The patient did not receive any treatment for the events. Since the vaccination, the patient was not tested for COVID-19. The outcome of the events was not resolved.  Upon follow up, the patient confirmed that she knew of the adverse events on 16Feb2021 but reported on 17Feb2021.  Follow-up attempts completed. No further information expected.
When the vaccine was administered, it was painful and burned. My left arm was sore, but it became worse. By that evening it was tender to the touch and stayed that way for about 2 days. I could not lay on my left side at all because it hurt so bad. After the second day, the pain moved from my arm to my left shoulder and settled between my shoulder and the base of my neck. The muscles are tense and at times a sharp pain shoots from the base of my neck, through my left shoulder and down my arm to the point of the injection. Today makes 2 weeks that this pain has been in my shoulder. Met with Dr. today and he advised me to take an ibuprofen for inflammation and to let him know if it gets any worse.
Weak; Feeling tired; Nauseous; Headache; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA, HEADACHE, FATIGUE, and NAUSEA in a 31-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 019B21A) for COVID-19 vaccination.     Concurrent medical conditions included Depression. Concomitant products included LATUDA and PAROXETINE for Depression, CLONAZEPAM for an unknown indication.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Mar-2021, the patient experienced HEADACHE. On an unknown date, the patient experienced ASTHENIA, FATIGUE, and NAUSEA. The patient was treated with TYLENOL at an unspecified dose and frequency; NAPROXEN and IBUPROFEN. At the time of the report, ASTHENIA, HEADACHE, FATIGUE, and NAUSEA outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       This case was linked to US-MODERNATX, INC. MOD-2021-080487 (E2B Linked Report). This case was linked to MOD-2021-080487 (Patient Link). Sender's Comments:  US-MODERNATX, INC. MOD-2021-080487.
positive diagnosis for COVID-19; positive diagnosis for COVID-19; This is a spontaneous report from a contactable other healthcare professional (patient herself). A 34-years-old female patient received first dose of bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on 18Dec2020 as single dose and second dose (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on 08Jan2021 as single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. On 11Feb2021, the patient had positive diagnosis for covid-19. The patient underwent lab tests which included sars-cov-2 test: positive on 11Feb2021. The outcome of the events was unknown.  Follow-up attempts are completed. No further information is expected.; Sender's Comments: The efficacy of a drug varies from patient to patient and can be affected by different factors; however, a contributory role of the suspect product bnt162b2 to the reported vaccination failure / COVID-19 cannot be ruled out.
Information has been recvd from 2 registered nurses concerning a male who in approximately 1/1998 was vaccinated with pneumococcal vaccine 23 polyvalent. Subsequently, pt experienced swelling at the injection site. The injection area was red, and he also experienced nausea and fatigue for a few days. The swelling went down without any medical treatment. Addtl info is not expected.
Day 1: Suffer debilitating pain/weakness in left arm about three hours after PNEUMOVAX injection. Shooting pains up and down the left arm and virtual paralysis of the arm. Cold packs, NSAIDS. Day 2-5: heat and NSAIDS. Hot, red, spot below pneumonia shot spot on inner upper arm on day three persists through day 5. Cannot lift arm above waist. Cannot dress and undress myself. Day 5: visit urgent care. Emergency Department recommended. See #12 on VAERS reporting system form for results of ED visit. Elevated ESR = 67. Receive MEDROL DOSEPACK 4 mg oral tablets, 21 tabs taken over 6 days. Days 6 - 11: continued MEDROL, symptoms abate, can move arm. Soreness and weakness continue. Day 14: visit internist and receive order for physical therapy.
No further AE; temperature excursion; This spontaneous report was received from a practice manager and refers to a patient of unknown age and gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided.  On 24-SEP-2020, the patient was vaccinated with an improperly stored dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) 1 injection, lot # 1621931, expiration date: 26-JAN-2022 (injection site and route of administration were not provided) for prophylaxis.  On 04-AUG-2020, the administered dose experienced the temperature excursions of below 2 degrees Celsius (C) (1.1 C) for 27 hours and 45 minutes and above 9 degrees Celsius (9 C) for 1 hour and 15 minutes. The digital data logger was involved. No previous temperature excursion had occurred. No further adverse events (AE) were reported.  This is one of multiple reports received from the same reporter. combinationproductreport: Yes; brandname: GARDASIL 9 SYRINGE (DEVICE); commondevicename: HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast); productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.; devicelotnumber: 1621931; expirationdate: 26-JAN-2022; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; evaluatedbymfr: Not returned to manufacturer; reasonfornoneval: 81 Other;  followupadditionalinfo :Yes; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability; Sender's Comments:  US-009507513-2010USA001083:
55 patients received a dose of a vial after 12 hours of initial puncture; This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (55 patients received a dose of a vial after 12 hours of initial puncture) in a 42-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Oct-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (55 patients received a dose of a vial after 12 hours of initial puncture). On 15-Oct-2021, EXPIRED PRODUCT ADMINISTERED (55 patients received a dose of a vial after 12 hours of initial puncture) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Vial was obtained on 06-JAN-2021 and dose given at time of puncture was on 09-MAR-2021 and kept in freezer until date of puncture, then stored in refrigerator. No concomitant medications were provided by the reporter. No treatment medications were provided by the reporter.
Patient Received his 2nd dose Pfizer COVID vaccine (LOT#: FL0007) at 1632 on 1/10/22. Patient alerted RN that he felt dizzy and nauseous. RN alerted other RN. Additional RN arrived on scene at 1635. Patient stated that he felt dizzy, nauseous and he felt like he was going to vomit. RN took patients vital signs at 1635. BP: 82/54, O2: 99% HR: 85. At 1647 patient stated that he felt "like someone was touching his chest." RN put pulse oximeter on patients finger. O2:99%, HR: 90. Patient denied any discomfort or pain in chest. Patient denied any tachycardia. RN retook patients vital signs at 1650. BP: 90/50, HR: 70, O2: 99%. Patient completed his 30 minutes of observation. Patient stated that he was feeling better and that his symptoms had subsided. Patient did not report any new symptoms. Patient and his mother were educated on signs and symptoms of adverse effects of COVID vaccine and when to seek help from EMS. Patient and his mother agreed and verbalized understanding. Patient left vaccination site at 1700 with his mom unassisted and with a steady gait.
Swollen lymph nodes in armpit; Fatigue; Painful joints; This is a spontaneous report from a non-contactable consumer, the patient. A 37-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration on an unknown date in 2021 (at the age of 37-years-old) and also received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8736) via an unspecified route of administration in the left arm on an unknown date in 2021 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in 2021, the patient experienced swollen lymph nodes in armpit, fatigue and painful joints. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events swollen lymph nodes in armpit, fatigue and painful joints were resolving at the time of report.  No follow-up attempts are possible. No further information is expected.
R09.02 HYPOXIA 7/2/2022 ALTERED MENTAL STATUS, UNSPECIFIED
At injection site, Continued severe right shoulder pain upper arm pain near acromnion for greater than 3 weeks especially with lifting the arm